1. Home
  2. Research and Funding
  3. Current Funding Opportunities
  4. New Directions in Hematology Research (SHINE-II) (R01 Clinical Trial Optional)

New Directions in Hematology Research (SHINE-II) (R01 Clinical Trial Optional)

This Funding Opportunity Announcement (FOA) is calling for R01 grant applications in nonmalignant hematology research. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the National Heart, Lung, and Blood Institute (NHLBI), and the National Institute on Aging (NIA) have joined together to build and promote research activities in nonmalignant hematology. Innovative research project applications that will steer the field in new directions are invited. Each project will propose proof of principle research that is tightly focused into one specific aim and is directed at validating novel concepts and approaches that promise to open up new pathways for discovery. Research applications submitted under this FOA should be more limited in scope (a single central aim) and duration (1-3 years) than typical R01 grant applications.

Funding Opportunity Details

PAS-18-730
None

Terry Rogers Bishop, Ph.D.; Cindy N. Roy, Ph.D.

Key Dates

5/5/2018

Not Applicable

Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.